Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
about
VHL type 2B mutations retain VBC complex form and functionSPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancerState of the science: an update on renal cell carcinomaGenetic and Chromosomal Aberrations and Their Clinical Significance in Renal NeoplasmsThe PI3K/AKT Pathway and Renal Cell CarcinomaHuman health effects of trichloroethylene: key findings and scientific issuesMetastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalitiesPD-1 as an emerging therapeutic target in renal cell carcinoma: current evidenceThe metabolic basis of kidney cancerCirculating biomarkers in advanced renal cell carcinoma: clinical applicationsEffects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.Choosing the right cell line for renal cell cancer researchIntegrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United StatesSpecific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growthDevelopment of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolutionThe Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.Management of Gene Variants of Unknown Significance: Analysis Method and Risk Assessment of the VHL Mutation p.P81S (c.241C>T)Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinoma.Validation of housekeeping gene and impact on normalized gene expression in clear cell renal cell carcinoma: critical reassessment of YBX3/ZONAB/CSDA expressionThe VHL-dependent regulation of microRNAs in renal cancer.Molecular genetics of clear-cell renal cell carcinomaBirt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and womenMolecular sub-classification of renal epithelial tumors using meta-analysis of gene expression microarrays.Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factorsMolecular diagnosis and therapy of kidney cancer.LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancerThe genetic basis of kidney cancer: a metabolic diseaseMolecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns.GPC3 reduces cell proliferation in renal carcinoma cell linesFructose-1,6-bisphosphatase opposes renal carcinoma progressionClear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.BAP1 loss defines a new class of renal cell carcinoma.microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasionLiquid biopsy: monitoring cancer-genetics in the blood.Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications.Renal cancer biomarkers: the promise of personalized careEpidemiology and risk factors for kidney cancer.
P2860
Q21144205-653084C3-ECE4-43CB-AA63-11EA62A1213AQ24339492-B138CAF4-52CF-4854-B5E6-707BAF603A1CQ24630685-8BB82950-5A3B-42B2-8F49-D13EE74EE810Q26785930-46F49C6A-3F55-47C3-9E54-E6DE57DFC255Q26800216-3E899C52-E671-4277-A016-1F21F8A51058Q26825606-C0A604F9-82D5-4970-8074-7213165E4042Q26852437-108B5CEB-2C42-4231-BE36-2A796B1D4FC0Q26865789-3BD965FF-C659-412E-B85B-8AFB3CEF76EBQ27023273-D092273B-30B9-46AD-94F7-492DD65C64ACQ27023770-64EE09FA-4649-4880-8F34-EB8156EC1C60Q27852038-B2B88A32-F03F-42B4-A141-CEE52E289FB7Q27852466-439679C6-60DA-43B2-AB0F-9D2D054C2B1BQ28073283-83350D82-B898-4130-9558-FF4640B84BA1Q28487676-DC3D3EF0-1F7D-4B07-A3CE-76D17273E462Q28542417-36AC5C02-9AAC-4CB6-94A6-FE811111BA3AQ28655705-0774013B-21D6-4471-9F92-AAA21EAA216DQ30277177-965D19A1-04A7-463F-91FC-E2BBAF5C491FQ30401951-2FF46798-EF35-4926-832C-97E06DE3809FQ33573577-300F1E9D-74D4-4DC8-9847-E4B518448AB1Q33712289-838A3278-34C7-4A5A-A265-4AF4B0DE5F1CQ33724729-B00E828C-572C-46FE-908C-B31AAC9B4325Q33729097-9D23326F-049F-40F7-8E5B-60A7D3563CACQ33772820-943F76D1-1A41-4A8F-8657-26F26D039EE3Q33901888-7BF44CA3-6DA4-425F-89BA-EA0340D97E5CQ33982903-39E3C6AA-825E-477B-8850-F1299ECA2D36Q34055338-32BDF292-0E28-454C-9683-378CD587CF9EQ34065685-D52AD975-0BA8-4B9B-AEE5-8623E94DF9D1Q34072715-EF365A9A-4D28-4381-B57C-98E13E2BB32FQ34087148-40F35478-368C-44EF-9D82-1E764B1670CFQ34146450-5DB67E0D-4E51-4EAA-95F2-E1F7515E2909Q34169151-C6B80544-E4BB-4113-AB33-C231E3A7FC09Q34173576-616A0AC0-E633-43D6-A3FB-903FD09FAD0DQ34186632-AFEBC9F0-ABF9-4EF0-A806-CF96EC038359Q34199816-5A9B0B27-3CD1-4EB8-B6D2-B66A3535D321Q34280223-1B76DFB5-6460-48FD-8C4B-DB3CFE5EBDA7Q34299534-C2586211-6436-4935-B057-8DBD754164C3Q34356149-434491D8-2D2A-4E46-8D13-BD8FAB4A59E0Q34414411-F1150967-9E6A-4F75-A035-DC7707295BC3Q34422845-B40400A2-B40A-4622-9AC9-08C4A7743AC8Q34449963-A316258E-A6B1-4D16-BC4F-96D22EE62A3F
P2860
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
@en
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.
@nl
type
label
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
@en
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.
@nl
prefLabel
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
@en
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.
@nl
P2093
P2860
P50
P1476
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
@en
P2093
Anush Mukeria
Berton Zbar
Erich Jaeger
Frederic M Waldman
Gary F Gerard
Hellena Kollarova
Jeffrey A Durocher
Jorge R Toro
Laura S Schmidt
Lee E Moore
P2860
P304
P356
10.1158/1078-0432.CCR-07-4921
P407
P50
P577
2008-08-01T00:00:00Z